Pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research across antimicrobial resistance, tobacco harm reduction and smoking cessation, and pandemic preparedness, with a focus on health systems, policy, and population-level risk.
About
Yusuff Adebayo Adebisi is a pharmacist and epidemiologist advancing equity-driven, policy-relevant public health research. He serves as Director of Research at Global Health Focus, leading applied research and capacity-strengthening initiatives across the Global South.
His work focuses on antimicrobial resistance, tobacco harm reduction, and pandemic preparedness, with a strong emphasis on real-world evidence, administrative data, and translating science into policy impact. He actively promotes bidirectional knowledge exchange between the Global North and South.
Explore
Research, career, funding and recognition.
Blog
Thoughts on public health, equity, global health policy, and more.
5 October 2026
A longitudinal study of 19,609 UK adults in Understanding Society found that functional disability was not associated with later exclusive vaping or dual use, but was linked to a higher relative likelihood of taking up exclusive cigarette smoking — an adjusted RRR of 1.41, rising to 1.67 among people reporting two or more disability domains.
Read article →19 August 2026
Bacterial antimicrobial resistance was directly attributable to 1.27 million deaths in 2019, and around 1.3 billion people — roughly one in six worldwide — experience significant disability. Drawing on a 2024 correspondence in The Lancet, this article argues that disability inclusion belongs in AMR research, national action plans and antimicrobial stewardship from the start.
Read article →6 August 2026
A systematic review and meta-analysis of 10 population-based studies and more than 700,000 participants found no statistically clear link between exclusive e-cigarette use and hypertension, while dual use of e-cigarettes and cigarettes was associated with 41% higher odds of prevalent and 35% higher risk of incident high blood pressure.
Read article →Universities, funders, programmes and research communities connected to my academic and research journey.
Contact
I welcome enquiries about research collaborations, speaking engagements, peer review, consultancy, or mentorship. Don't hesitate to reach out.
